Capricorn Partners funding news – Capricorn Partners has Started the Capricorn Healthtech Fund II With an Initial Funding of €51 Million

This new fund follows the success of the previous one and will invest in companies focused on health tech, medical devices, digital health, and diagnostics.

Filip Pintelon, Investment Partner Health with the Capricorn Healthtech team said, “With Capricorn Healthtech Fund II, we invest in healthcare transformers and facilitate their integration into mainstream healthcare practices, making healthcare more accessible and efficient,”.

The new funds will be used to support early and growing health-tech companies. Capricorn Partners aims to help these companies make a big impact on healthcare by improving patient outcomes and medical processes.

This approach meets the growing need for affordable, innovative healthcare solutions in Europe and beyond. Capricorn believes that personalising healthcare can lower costs and improve patient care. A 2024 report from the European Commission shows that healthcare spending makes up about 10% of the GDP in most EU countries.

Technologies like AI help personalise healthcare from prevention and diagnosis to treatment. They allow healthcare providers to offer more customised services, making care more efficient and improving patient satisfaction.

Capricorn believes that using these new technologies can save money in healthcare systems while still providing high-quality, personalised care.

Ulrike Kostense, Lead Indirect Investments said, "Among the new LPs joining the fund are Invest-NL and Sensinnovat, Invest-NL is committed to driving the essential transition in healthcare by investing in innovations that prevent, replace or shift expensive care. Capricorn Partners brings the expertise needed to guide this process effectively, making them a valuable partner within our ecosystem.”

Also Geert Reynders, Chief Investment Officer at Sensinnovat comments: “We are excited to partner with Capricorn Healthtech Fund II, as it aligns with our commitment to investing in healthtech solutions that improve lives and strengthen healthcare systems worldwide”.

They are joining current key investors such as Quest for Growth, AG Insurance/Ageas, PMV, finance&invest.brussels, and KU Leuven Research & Development.

Gilke Eeckhoudt, Chief Development & Sustainability Officer Ageas and Wim Vermeir, Chief Investment Officer AG Insurance said, “Our investment in the Capricorn Healthtech Fund II aligns perfectly with the strategy of Ageas and AG Insurance to invest in the real economy and to follow the latest developments in health and technology, and furthermore illustrates the longstanding partnership with Capricorn Partners”.

About Capricorn Partners

Capricorn Partners, founded in 1993, is an investment firm that focuses on venture capital, especially in technology, life sciences, and clean-tech. This has resulted in successful exits like Cartagenia, Bluebee, and Sequana Medical, as well as success stories like icometrix.